(19)

(11)

EP 3 762 508 A2

(12)

(88) Date of publication A3: 26.12.2019 (43) Date of publication: 13.01.2021 Bulletin 2021/02 (21) Application number: 19764885.0 (22) Date of filing: 08.03.2019

(51) International Patent Classification (IPC):  C12Q 1/6809(2018.01) C12Q 1/6853(2018.01) C12Q 1/6893(2018.01) G01N 33/533(2006.01) G16B 25/20(2019.01) C12Q 1/6837(2018.01) C12Q 1/689(2018.01) C12Q 1/6895(2018.01) G16B 20/10(2019.01) G16B 25/30(2019.01) (86) International application number: PCT/US2019/021317 (87) International publication number: WO 2019/173695 (12.09.2019 Gazette 2019/37)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 08.03.2018 US 201815916062 08.03.2018 US 201815916036 11.10.2018 US 201816158276 (71) Applicant: Pathogendx, Inc. Scottsdale AZ 85260 (US)	(72) Inventors: HOGAN, Michael, Edward Stony Brook, NY 11790 (US) MAY, Melissa, Rose Tucson, AZ 85715 (US) EGGERS, Frederick, Henry Sahuarita, AZ 85629 (US) (74) Representative: Beck Greener LLP  Fulwood House 12 Fulwood Place London WC1V 6HR London WC1V 6HR (GB)